TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Thu Mar 19

NL

Article

TMFBiologyFool published an article 2:04 PM

3 Big Pharma Stocks Wall Street Is Wrong About

Three contributors weigh in.

Wed Mar 18

NL

Article

TMFBiologyFool published an article 3:15 PM

Confessions of a Value Investor Stuck in a High-Growth Industry

It's OK to buy premium-priced biotechs.

NL

Article

TMFBiologyFool published an article 1:46 PM

Best One-Drug Wonder Stock for 2015

You've got to start somewhere. Here's our top picks of biotechs with just one drug on the market.

Fri Mar 13

NL

Article

TMFBiologyFool published an article 5:47 PM

Orexigen Therapeutics, Inc. -- Stuck Between an Obese Rock and a Hard Place

The obesity drugmaker had good data that the FDA didn't want disclosed.

Tue Mar 10

NL

Article

TMFBiologyFool published an article 1:56 PM

3 Biotech Stocks to Buy If the Sector Crashes

Our experts recommend Alnylam Pharmaceuticals, Celgene, and Biogen Idec.

Mon Mar 9

NL

Article

TMFBiologyFool published an article 1:25 PM

3 Biotech Stocks to Buy in March

Our experts weigh in on why they like Vertex Pharmaceuticals, Neuralstem, and Intercept Pharmaceuticals.

Thu Mar 5

Rule Breakers article.

TMFBiologyFool published an update. 7:51 PM

NL

Article

TMFBiologyFool published an article 6:52 PM

Emergent Biosolutions Inc's Unexpected Surprise

With preannounced revenue and earnings, Emergent Biosolutions' fourth-quarter earnings were supposed to be boring.

NL

Article

TMFBiologyFool published an article 3:16 PM

3 Big Pharma Stocks to Buy in March

Our experts weigh in.

Tue Mar 3

NL

Article

TMFBiologyFool published an article 12:49 PM

3 Easy Ways to Fail When Investing in Biotech Stocks

Our experts help you avoid these common mistakes.

Mon Mar 2

NL

Article

TMFBiologyFool published an article 9:28 PM

5 Things MannKind Corporation's Management Wants You to Know

While info on Afrezza's launch was limited, some info on its next drugs flowed.

NL

Article

TMFBiologyFool published an article 8:24 PM

Arena Pharmaceuticals, Inc. Earnings: Explaining the Wonky Trends

A fourth-quarter slowdown and relatively flat sales over the year.

Rule Breakers article.

TMFBiologyFool published an update. 10:20 AM

Fri Feb 27

NL

Article

TMFBiologyFool published an article 2:55 PM

Whoa, a Profit for Isis Pharmaceuticals Inc.

Don't get too excited just yet.

Thu Feb 26

Rule Breakers article.

TMFBiologyFool published an update. 10:00 AM

Rule Breakers article.

TMFBiologyFool published an update. 10:00 AM

Wed Feb 25

NL

Article

TMFBiologyFool published an article 7:42 PM

"Profitability" in Sight for BioMarin Pharmaceutical Inc.

2017 could be the year for the orphan-drug maker.

NL

Article

TMFBiologyFool published an article 1:59 PM

Orexigen Therapeutics, Inc. Gives the Skinny on Its Drug Launch

Fourth-quarter earnings were nothing to get excited about, but the Contrave launch trajectory looks good so far.

Tue Feb 24

NL

Article

TMFBiologyFool published an article 10:06 PM

MannKind Corporation in Transition

A drug on the market for two weeks makes for a boring earnings call.

NL

Article

TMFBiologyFool published an article 7:36 PM

Looking Ahead at Exelixis, Inc.

The biotech faces two major value-creating events in 2015.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 97.64
Player Rank 1778 out of 75160
Score 1863.23
Score Change Today +33.94
Accuracy 67.79%
Active Picks 72
Total Picks 213
Best Pick ISIS (+377.93)
Worst Pick INCY (-897.71)
Average Score per Pick 8.75
Charms Earned 10
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Three stars, 500 posts CAPS All Star
Board Posts 928
Recs Received 982
People who have rec'd these posts 380
Recs to Posts Ratio (last 30 days) N/A
Threads Started 90
Threads Started Percentage 9.70 %
Most Frequent Board Buying or Selling a Home
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 48.17 %
Show TMFBiologyFool’s 10 Latest Posts